We hypothesized that increased KLK6 and p53 expression contributed to acquired resistance to AF-mediated cell death and that augmented apoptotic events in AF-sensitive cells likely reflect low KLK6 and p53 levels. This evidence concerns the gene TP53 and atrial fibrillation.